A new anorexic agent, WY-5244: cardiovascular actions and influence on sympathomimetic amines.
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001067:Appetite Depressants / Q000494:pharmacology*; D001285:Atropine / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects*; D002302:Cardiac Output / Q000187:drug effects*; D002744:Chlorpheniramine / Q000494:pharmacology; D003913:Dextroamphetamine / Q000494:pharmacology; D004285:Dogs; D004298:Dopamine / Q000494:pharmacology; D004336:Drug Antagonism; D004809:Ephedrine / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D006339:Heart Rate / Q000187:drug effects*; D006584:Hexamethonium Compounds / Q000494:pharmacology; D006632:Histamine / Q000494:pharmacology; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D008616:Mephentermine / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects*; D009638:Norepinephrine / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D010656:Phenylephrine / Q000494:pharmacology; D010879:Piperazines / Q000494:pharmacology; D012110:Reserpine / Q000494:pharmacology; D014439:Tyramine / Q000494:pharmacology; D014630:Vagus Nerve / Q000502:physiology; D014655:Vascular Resistance / Q000187:drug effects*
D001067:Appetite Depressants; D006584:Hexamethonium Compounds; D010879:Piperazines; D010643:Phenoxybenzamine; D010656:Phenylephrine; D002744:Chlorpheniramine; D001285:Atropine; D006632:Histamine; D012110:Reserpine; D004809:Ephedrine; D007545:Isoproterenol; D000109:Acetylcholine; D008616:Mephentermine; D003913:Dextroamphetamine; D004298:Dopamine; D009638:Norepinephrine; D014439:Tyramine; D004837:Epinephrine